Genesis Bioventures Announces Breast Cancer Marker Receives Diagnostic and Therapeutic Patent Approval
2nd Feb 2006, 17:30 GMT
NEW YORK, Feb. 2 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
Genesis Bioventures Announces Breast Cancer Marker Receives Diagnostic and Therapeutic Patent Approval related news:
- Genesis Bioventures Announces Breast Cancer Marker Receives Diagnostic and Therapeutic Patent Approval — Mammography News from StratCenter.com
- Genesis Bioventures Announces US Patent for Mad Cow Disease Rapid Test — Laboratory News from StratCenter.com
- Mammogram — MedTerms Word of the Day
- Genesis Bioventures Announces United States Patent for Mad Cow Disease Rapid Test — PR Newswire: All Releases
- Tamoxifen: Is it Getting a Bad Rap? — Breast Cancer Chronicles
- Radiation cuts risk of breast cancer return (Reuters) — Yahoo! News: Health News
- Provectus Receives 4th Pharmaceutical Patent for Anti-Cancer Agents — Ultrasound News from StratCenter.com
- Calendar designed to create breast health conversation — The Cancer Blog
- Radiation cuts risk of breast cancer return — Reuters: Health
- Civil disobedience for breast cancer drug — The Cancer Blog
Latest news from RedOrbit News - Health:
- Pet Shop Boys Fans Know Better _ Why Bother Sharing?
- Corcept Tests Psych. Major Depression Rx
- On Its 30th Anniversary, Smokeout Provides Even More Help Quitting Smoking
- Health Plans and Disease Management Companies Are Seeking To Reduce the Use of the ER for Non-Urgent Care - Urgent Emergency Room Usage October 18, 2006 Audio Conference on CD-ROM
- Invitation Conference Call Analyst Meeting
- As Benefit Costs Rise, Employee Retirement Savings Decline
- Aetna to Help Members Quit Tobacco With New Tobacco Cessation Program
- Lilly: Arxxant Cuts Sight Loss in Diabetes
- SW Doctors PA Launch Affordable Primary Care (APC) Services
- Health Savings Technology Appoints New Management Team to Spearhead Growth in Customer-Directed Healthcare Industry